Aurobindo Pharma Ltd. has submitted a Compliance Certificate under Regulation 40(9) to confirm that there were no requests for share transfers or exchanges from April 1, 2023, to March 31, 2024, and all requests for transmission and duplicate certificates were handled timely, except those rejected on technical grounds.